Literature DB >> 28263922

Citrulline and Monocyte-Derived Macrophage Reactivity before Conditioning Predict Acute Graft-versus-Host Disease.

Thomas Hueso1, Valérie Coiteux2, Marie Joncquel Chevalier Curt3, Julien Labreuche4, Thierry Jouault1, Ibrahim Yakoub-Agha5, David Seguy6.   

Abstract

During conditioning, intestinal damage induces microbial translocation which primes macrophage reactivity and leads to donor-derived T cell stimulation. Little is known about the role of intestinal health and macrophage reactivity before conditioning in the development of acute graft-versus-host disease (aGVHD) in patients undergoing allogeneic hematopoietic cell transplantation (allo-HCT). We assessed (1) citrulline, a surrogate marker of functional enterocyte mass and (2) circulating monocyte-derived macrophage reactivity, before allo-HCT. Forty-seven consecutive patients were prospectively included. Citrulline levels from blood samples withdrawn 30 days before transplantation were assessed using liquid chromatography combined with mass spectrometry. Monocyte-derived macrophages were isolated and incubated with 5 pathogen-associated molecular patterns: lipopolysaccharide, PamCSK4, flagellin, muramyl dipeptide, and curdlan. Multiplex fluorescent immunoassay on culture supernatant assessed levels of TNF-α, IL-1β, IL-6, and IL-10 in each condition. Citrulline and cytokine levels were analyzed relatively to aGVHD onset within 100 days after transplantation. Citrulline levels were lower in the aGVHD group (n = 20) than in the no-aGVHD group (n = 27) (P = .005). Conversely, IL-6 and IL-10 were greater in aGVHD group, especially after curdlan stimulation (P = .005 and P = .012). Citrulline levels ≤20 µmol/L, IL-6 ≥ 332 pg/mL, and IL-10 ≥ 90 pg/mL were associated with aGVHD development (log-rank test, P = .002, P = .041, and P < .0001, respectively). In multivariate analysis, IL-10 ≥ 90 pg/mL, myeloablative conditioning, and citrulline ≤20 µmol/L remained independent factors of aGVHD development (hazard ratio [HR],  8.18, P = .0003; HR, 4.28, P = .006; and HR, 4.43, P = .01, respectively). Preconditioning citrulline and monocyte-derived macrophage reactivity are objective surrogate markers suitable to identify patients at risk of developing aGVHD. This work highlights the influence of preconditioning status in aGVHD development.
Copyright © 2017 The American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Citrulline; Interleukin; Intestinal damage; Macrophage

Mesh:

Substances:

Year:  2017        PMID: 28263922     DOI: 10.1016/j.bbmt.2017.03.005

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN: 1083-8791            Impact factor:   5.742


  5 in total

1.  A distinct glycerophospholipid metabolism signature of acute graft versus host disease with predictive value.

Authors:  Yue Liu; Aijie Huang; Qi Chen; Xiaofei Chen; Yang Fei; Xiaoming Zhao; Weiping Zhang; Zhanying Hong; Zhenyu Zhu; Jianmin Yang; Yifeng Chai; Jianmin Wang; Xiaoxia Hu
Journal:  JCI Insight       Date:  2019-07-25

2.  Pretransplant Serum Citrulline Predicts Acute Graft-versus-Host Disease.

Authors:  Armin Rashidi; Ryan Shanley; Shernan G Holtan; Margaret L MacMillan; Bruce R Blazar; Alexander Khoruts; Daniel J Weisdorf
Journal:  Biol Blood Marrow Transplant       Date:  2018-07-07       Impact factor: 5.742

3.  Innate Immune Determinants of Graft-Versus-Host Disease and Bidirectional Immune Tolerance in Allogeneic Transplantation.

Authors:  Anouk A J Hamers; Sunil K Joshi; Asha B Pillai
Journal:  OBM Transplant       Date:  2019-01-31

Review 4.  Biomarkers in Graft-Versus-Host Disease: from Prediction and Diagnosis to Insights into Complex Graft/Host Interactions.

Authors:  Fiona C He; Shernan G Holtan
Journal:  Curr Hematol Malig Rep       Date:  2018-02       Impact factor: 4.213

5.  Impact and consequences of intensive chemotherapy on intestinal barrier and microbiota in acute myeloid leukemia: the role of mucosal strengthening.

Authors:  Thomas Hueso; Kenneth Ekpe; Camille Mayeur; Anna Gatse; Marie Joncquel-Chevallier Curt; Guillaume Gricourt; Christophe Rodriguez; Charles Burdet; Guillaume Ulmann; Christel Neut; Salah-Eddine Amini; Patricia Lepage; Bruno Raynard; Christophe Willekens; Jean-Baptiste Micol; Stéphane De Botton; Ibrahim Yakoub-Agha; Frédéric Gottrand; Jean-Luc Desseyn; Muriel Thomas; Paul-Louis Woerther; David Seguy
Journal:  Gut Microbes       Date:  2020-11-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.